OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cholangiocarcinoma
Samantha Sarcognato, Diana Sacchi, Matteo Fassan, et al.
Pathologica (2021) Vol. 113, Iss. 3, pp. 158-169
Open Access | Times Cited: 122

Showing 1-25 of 122 citing articles:

The interplay of signaling pathways with miRNAs in cholangiocarcinoma pathogenicity and targeted therapy
Mohamed Bakr Zaki, Ahmed I. Abulsoud, Shereen Saeid Elshaer, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154437-154437
Closed Access | Times Cited: 48

The evolving role of liver biopsy: Current applications and future prospects
Purva Gopal, Xiaobang Hu, Marie E. Robert, et al.
Hepatology Communications (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1

The SLIT/ROBO Pathway in Liver Fibrosis and Cancer
Sreenivasulu Basha, Brady Jin-Smith, Chunbao Sun, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 785-785
Open Access | Times Cited: 17

Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies
Hannah Hisham Rashwan, Ayman Taher, H. A. Hassan, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155223-155223
Closed Access | Times Cited: 6

Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2/glutamine pathway
Phonpilas Thongpon, Kitti Intuyod, Sasitorn Chomwong, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6

Immunotherapy and targeted therapy for cholangiocarcinoma: Artificial intelligence research in imaging
Jiong Liu, Jian Shu
Critical Reviews in Oncology/Hematology (2024) Vol. 194, pp. 104235-104235
Closed Access | Times Cited: 5

Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing
Albrecht Stenzinger, Arndt Vogel, Ulrich Lehmann, et al.
Cancer Treatment Reviews (2023) Vol. 122, pp. 102649-102649
Open Access | Times Cited: 14

Advanced endoscopy meets molecular diagnosis of cholangiocarcinoma
Massimiliano Cadamuro, Ahmad Al-Taee, Tamas A. Gonda
Journal of Hepatology (2023) Vol. 78, Iss. 5, pp. 1063-1072
Open Access | Times Cited: 13

Cholangiocarcinoma: Pathologic and Molecular Classification in the Era of Precision Medicine
Purva Gopal, Marie E. Robert, Xuchen Zhang
Archives of Pathology & Laboratory Medicine (2023) Vol. 148, Iss. 3, pp. 359-370
Open Access | Times Cited: 13

Recent Advances in Pathology of Intrahepatic Cholangiocarcinoma
Joon Hyuk Choi, Swan N. Thung
Cancers (2024) Vol. 16, Iss. 8, pp. 1537-1537
Open Access | Times Cited: 5

Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma
Xu Chen, Bo Sun, Yu Chen, et al.
Translational Oncology (2024) Vol. 43, pp. 101905-101905
Open Access | Times Cited: 4

Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids
Ann‐Kathrin Lederer, Nele Görrissen, Tinh Thi Nguyen, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study
Aung Naing, Amit Mahipal, Milind Javle, et al.
Journal of Immunotherapy and Precision Oncology (2025) Vol. 8, Iss. 1, pp. 71-81
Open Access

Actualización del manejo clínico del Colangiocarcinoma Intrahepático Parte I: Epidemiología, Clasificación y Diagnóstico
Deycies Ivonne Gaete Letelier, Alexandre Sauré Maritano, Carlos Mandiola
Revista de cirugía (2025) Vol. 77, Iss. 1
Open Access

Cystatin B Promotes the Proliferation, Migration, and Invasion of Intrahepatic Cholangiocarcinoma
Dai Zhang, Bao‐Ye Sun, Jing-Fang Wu, et al.
Current Oncology (2025) Vol. 32, Iss. 2, pp. 56-56
Open Access

Case report: Rare observation of thyroid-like cholangiocarcinoma
Е. В. Бондаренко, Dmitriy Kalinin, L. S. Urusova, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access

Preoperative Imaging Assessment and Staging of Perihilar Cholangiocarcinoma: Tips and Pitfalls
Yu Yong, Zhuyi Rebekah Lee, Nicholas Yock Teck Soh, et al.
Journal of the Korean Society of Radiology (2025) Vol. 86, Iss. 1, pp. 45-45
Open Access

Transplantation for Peri-Hilar and Intrahepatic Cholangiocarcinoma With mTOR Immunosuppression
Samar Semaan, Ashton A. Connor, Ashish Saharia, et al.
Transplantation Proceedings (2025)
Closed Access

Single-cell RNAseq reveals adverse metabolic transcriptional program in intrahepatic cholangiocarcinoma malignant cells
Christophe Desterke, Raquel Francés, Claudia Monge, et al.
Biochemistry and Biophysics Reports (2025) Vol. 41, pp. 101949-101949
Closed Access

Discovering new interaction between genes in extrahepatic Cholangiocarcinoma using Bayesian networks
Fatemeh Salboukh, Aria Jahanimoghadam, Yashar Mousavi
Network Modeling Analysis in Health Informatics and Bioinformatics (2025) Vol. 14, Iss. 1
Open Access

A drug-eluting balloon catheter coated with chitosan and paclitaxel-loaded poloxamer-stabilized PLA microparticles for the effective treatment of cholangiocarcinoma
Jin Sil Lee, Jaehee Jang, Hyeryeon Oh, et al.
Journal of Industrial and Engineering Chemistry (2025)
Closed Access

Application of CAPTURE Assay for Early Diagnosis and Prognosis in Bile and Blood of Cholangiocarcinoma
Yi-Cheng Tsai, Chien‐Jui Huang, Jui-Lin Chang, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access

Page 1 - Next Page

Scroll to top